Accession numbers are listed in the ‡ on the last page of this article.
Original Articles
Desmin-related myopathy with mallory body–like inclusions is caused by mutations of the selenoprotein N gene†
Article first published online: 25 MAR 2004
DOI: 10.1002/ana.20077
Copyright © 2003 American Neurological Association
Additional Information
How to Cite
Ferreiro, A., Ceuterick-de Groote, C., Marks, J. J., Goemans, N., Schreiber, G., Hanefeld, F., Fardeau, M., Martin, J.-J., Goebel, H. H., Richard, P., Guicheney, P. and Bönnemann, C. G. (2004), Desmin-related myopathy with mallory body–like inclusions is caused by mutations of the selenoprotein N gene. Ann Neurol., 55: 676–686. doi: 10.1002/ana.20077
- †
Publication History
- Issue published online: 21 APR 2004
- Article first published online: 25 MAR 2004
- Manuscript Accepted: 21 JAN 2004
- Manuscript Revised: 20 JAN 2004
- Manuscript Received: 18 SEP 2003
Funded by
- Institut National de la Santé et de la Recherche Médicale (National Institut of Health and Medical Research, ISERM)
- Association Française contre les Myopathies (French Association against Myopathies, AFM)
- Florence R.C. Murray Fellowship Program at The Children's Hospital of Philadelphia
- Abstract
- Article
- References
- Cited By
Abstract
Desmin-related myopathies (DRMs) are a heterogeneous group of muscle disorders, morphologically defined by intrasarcoplasmic aggregates of desmin. Mutations in the desmin and the α-B crystallin genes account for approximately one third of the DRM cases. The genetic basis of the other forms remain unknown, including the early-onset, recessive form with Mallory body–like inclusions (MB-DRMs), first described in five related German patients. Recently, we identified the selenoprotein N gene (SEPN1) as responsible for SEPN-related myopathy (SEPN-RM), a unique early-onset myopathy formerly divided in two different nosological categories: rigid spine muscular dystrophy and the severe form of classical multiminicore disease. The finding of Mallory body–like inclusions in two cases of genetically documented SEPN-RM led us to suspect a relationship between MB-DRM and SEPN1. In the original MB-DRM German family, we demonstrated a linkage of the disease to the SEPN1 locus (1p36), and subsequently a homozygous SEPN1 deletion (del 92 nucleotide −19/+73) in the affected patients. A comparative reevaluation showed that MB-DRM and SEPN-RM share identical clinical features. Therefore, we propose that MB-DRM should be categorized as SEPN-RM. These findings substantiate the molecular heterogeneity of DRM, expand the morphological spectrum of SEPN-RM, and implicate a necessary reassessment of the nosological boundaries in early-onset myopathies. Ann Neurol 2004

1531-8249/asset/olbannerleft.gif?v=1&s=d36d5ebb3caa1b29d7f078a97c52973b0963daf2)
1531-8249/asset/olbannerright.gif?v=1&s=078041b213f6959d63575a593f880457c45116f0)
1531-8249/asset/cover.gif?v=1&s=685ec69724c5ed4c8847ce939e70ceb45065856f)